Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18937638&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Update on the management of hyperuricemia and gout Pillinger MH; Keenan RTBull NYU Hosp Jt Dis 2008[]; 66 (3): 231-9Gout is the most common inflammatory arthritis in the United States, with more than three million sufferers. Management of gout has changed relatively little in the past 50 years, despite the fact that many gout patients have contraindications to one or more currently available gout therapies. However, recent insights into gout pathophysiology suggest that time is ripe for a change. This article reviews recent updates in the management of gout, including new insights into dietary management that may permit better control of hyuperuricemia. Also reviewed are the biological and clinical data behind newly-developed drugs for gout that are likely to receive serious consideration for FDA approval, and clinical use, in the foreseeable future.|*Risk Reduction Behavior[MESH]|Adrenocorticotropic Hormone/therapeutic use[MESH]|Alcohol Drinking/adverse effects[MESH]|Coffee[MESH]|Cytokines/antagonists & inhibitors[MESH]|Dairy Products[MESH]|Diet/adverse effects[MESH]|Dietary Carbohydrates/adverse effects[MESH]|Drugs, Investigational/therapeutic use[MESH]|Fructose/adverse effects[MESH]|Gout Suppressants/*therapeutic use[MESH]|Gout/etiology/immunology/*therapy[MESH]|Humans[MESH]|Hyperuricemia/etiology/immunology/*therapy[MESH]|Receptors, Melanocortin/agonists[MESH]|Treatment Outcome[MESH] |
